1. 1. (102) 7 23 1 (1) 1. 103 2,414 1
2. 2. 2. 1 1231 2674 2 () 101 1031281 99 3 101 10312 73 3,595 4 10312 21,176 62,744125,194 7,003 3. 1 3 9231.3%1033 50.7% 2 1038 34 2
3. 3. 3 5,000 3,000103924,4913 1,475 4. 1 103 1029,0114 1,855 2 6 103919,356 3 103 1283,481 4 1039 ()7532 4,881 5. 103 9()16,220 3 3
4. 4. 6. 34 910311 1,168 343367 7. 10311 89627 35 8. 103 98 124502,0001 1,791 (2) 1. CRC 1 1031120 2 1031 2. 124 1,277 37 3. 101 103 4
5. 5. 10 42 7,906 9,220 24 1,743 4. 3,000 103 11 1 5,493 7,399 1 1,465 3 5. 103 10 24 1,148 6. 103 6 3,134 1,739 (3) 1. 2. 103 170 ( 150 20 ) 3. 103 4 5
6. 6. 4. 103 10 1,053 4 5,333 5. 103 11 1,966 21 10 6. 70 103 94 4,492 7. 5,000 103 9 3,352 6,680 8. 7,200 3,600 103 9 70 564 12 9. 98 1039 33,933 10. 6
7. 7. 1,800 21 6,000103 4 1571,000 (4) 1. 1 2 4 2 1 23 2 4 2. 1 2 / 3 103 1 12 5 1,780 93.3 7
8. 8. 4 103 1 12 1,599 40 5 3. 1 (113)103 1 12 113 22 693 15 9,828 2 103 1 12 81 3 14 5,600 3 4 103 1 12 46 5 4. 8
9. 9. 1 103 1 12 21 318 188 2 103 5. 1 1) 103 1 12 110 2) 16 103 1 12 750 3) 103 1 12 443 4) 2 103 9
10. 10. 3 1) TAGV 103 12 TAGV 1 4,921 2) 3) 4) / / 6. 1 2 10
11. 11. 3 1,800 4 103 7 9 600 7. 103 3 5,000 4 (5) 1. 1 (CRPD) 103820103123 CRPD 1031127 2 CRPD 11
12. 12. CRPD 2. 1 10311579,209 474,410() 2 1957 242 3 99 103124,2939,117 4 103 1015 5 3. 1 3,5008,200 103 9153 34 12
13. 13. 2 1039 23,38518,758 3 103 11 309,94455 4 103 9 51,65354,099 4. 103(9)103412 274 1031024 3 () 1. 103 12 70 2. 13
14. 14. 103 26 144 74 103 1 7,858 2 7,471 3. 97 8 18 103 12 304 239 4. 103 1 12 1,039 1,413 5,000 5. 103 1 12 648 103 1,721 () 1. 103 12 6,761 3,900 1,553 14
15. 15. 3,252 10 6,697 2. 97 103 13 43 3. 90 100 25 103 12 146 863 () 1. 103 12 915 101 114 1,490 61 2. 86 103 12 8,040 3. : 217 ( 15
16. 16. 81.3) 4. 1: 98 2: 103 1 103 3 5 9 5 10 21 3: () 1. 40 65 3 1 55 65 1 102 181 103 1-9 156 2. 103 20 103 40 4 16
17. 17. 90% 3. 514 97.8% 215 4. 103 155 103 22 4 5 30 5. 103 2,500 6. 103 1-9 65 78 102 50 69 53.4 50-69 102.8 103 1-11 65 530 103 1-11 8,271 7. 103 22 17
18. 18. 1,826 9 8. 103 104 9. 102 22 1 WHO 2 2 APEC 3 103 2,400 (8 ) 3% 18
19. 19. () 1. 97 2.3% 103 33.2 155,288 2. 1 100 103 66 105 89 2 103 170 22 66 ( 105 89 ) 3 700 6 (11 )103 2 3 4 103 129 3. 1 99-103 28,901 19
20. 20. 2 100-103 () 2,394 ( 2,185 ) 4. 70% 36,631 9,538 11,362 7,847 1,391 2,124 5. 103 12 970 1,900 6. 103 1 8 104 1 16 63 15 7. 102 8 26 20
21. 21. 103 9 5 (1) 1. 103 11 1,233 2. 103 9 463 3. 102 30 4. 103 11 751 2.8% 5. 102 1 1 21
22. 22. 7 1 138.8 103 104 102 56.7 103 5 7 103 82.1 104 4 1 (2) 1. Tw-DRGs 1 103 1 (98 1-3 )4.40 4.15 5.69%(98 1-3 )4 5,278 4 8,771 3,493 7.72% 102 2 22
23. 23. 3 103 7 1 DRG 2 237 12 401 DRG 2. 1 11 (103 5.673 2.055 4.04 ) 2 1) 103 1-10 40.07 2) 103 1-10 9.38 3) 103 1-10 1.16 4) 103 1-10 5.6 5) B C 103 1-10 16.14 6) 103 1-10 21.72 103 1-10 33.96 3. 1 3 8 20 23
24. 24. 102 1 6 3.2 2 103 4 4. () 1 103 1 17 102 1 1 103 1.002 102 2 101 103 3.2 3 6 (98-103 ) 91.65 5. 24
25. 25. 39 (129 ) 103 3 11 1,400 1,067 86% 82% 84% (3) 1. 1 103 12 304 239 2 103 11 2,830 1.77 10.84 29.23 9,575 2,312 103 7 4.3 2. 1 103 10 25
26. 26. 4 2 103 10 1,806 4,772 3. 1 (IDS) 50 43 103 26 30 4-6 103 1-6 18.58 2.35 2 5.3 104 121 97 143 3 26
27. 27. 1,500 103 8 74 4. 1 50 2 100 7 1 102 1 102 13 4,861 3.69 103 1-10 10 9,094 2.8 (4) 1. 90 103 1-10 19% 15% 2. 103 1-6 72.5% () 27
28. 28. 3. 102 7 1 103 11 30 4,679 4. 103 12 HTA 10 3 (5) 1 . 103 12 31 493 2. ( 75% 60%) ( 103 9 28
29. 29. 474 404 (85.23%)) 3. 103 12 102 6 109 () 1. 0.5% 104 1 1 7.5% 8% 2. 97 10 1 17,280 104 1 1 18,282 3. 103 12 358 (97 10 103 10 ) 56% 103 12 142 103 610 4. 103 103 12 31 347 216 12 29
30. 30. 5.8% 5. () (97 10 104 1 ) 2 2,630 1,540 2 1,286 2,778 94.06% () 1. 103 9 2. 3. 103 4. 102 103 5. 103 30
31. 31. 6. 101102 103 (1) 1. 10 1 102 94.3% 177 1 98.5% 4 97.5%103 1-9 149.2 2. 103 12 2 531 98.2%103 18 85.2% 3. 2,000 5,000 8,500 103 5 2,682 1,591 6,059 31
32. 32. 1,824 13 8,454 99% 4. 103 177 76.6%103 6 45.8% 2005-201238% 103 12 2,061 100% 5. 103 792 103 1.069(102)(1.078) 6. 103 12 17,567 117 6299 102 APP 7. 103 2 18 8. 103 11 5 32
33. 33. 103.12.1 104.1.9 9 (2) 1. 7 7 103 1-6 56.3 2. 103 11 1 7 7 103 12 77.4 7 103 6 18 3. 4 5 103 36 1,726 95.4 99.3% 4. 103 316 98.4%103 20 4,641 97.2% 5. 3-4 1 101 47.4% 102 73%103 1-9 68.4 103 2,659 137 33
34. 34. 6.- e / 103 12 5,025 2,105 63 Teens 9 (3) 1. 103 12 11 AFHC 2. 103 19 151 3. 103 19 4. 103 2 1,499 5. 1 104 3 6 151 WHO WHO-HPH Recognition Project 21 34
35. 35. 2 99 103 2 88 173 29 103 - 103 169 3 103 APEC 503 6. 103 1 2,439 411 1 5 7. 103 2 103 8 238 2014 8 12 8. 103 1~10 12,068 51 35
36. 36. (4) 1. 103 523.8 217.8 80.2 125.2 100.6 1.2 5.1 2. 98 132.5 102 130.4 98 171.6 102 169.4 1.3% 98 95.1 102 94.7 0.4% 105 119.3 109 109 3. 92 96 48% 96 100 53% 5% 41% 46% 58% 62% 4. 36
37. 37. 18 96 17.2% 103 9.7% 5. 103 1 1 3 HPV 12 5 3 1 2 3 ( ) 1,306 72.5%1,305 72.5%1,299 72.1% 1 2 3 () 2,213 10.2%2,207 10.1%2,204 10.1% 6. 226 94 6 103 61 37
38. 38. 15 7. 103 55 3 ( ) 8 1,500 8. 101 1 50.6% 98 39% 11.6% (5) 1. 103 18 97 21.9% 16.4%6 89 97 23.7% 103 7.5% 2. 103 71 491 8,242 8,242 38
39. 39. 3,486 3. 103 4 1 12 15,635 347 63 4,000 1 96 4. 103 6 1 8 5. 2014 27,427 17,800 6. 200 103 ( ) 3,131 98.9% 100%103 (1-11 ) 11 5,565 39
40. 40. 102 45.6% (101.3- 103.11) 23 3,100 6 (91.9-101.2)23.9% 28.8%( 103.7) 20.5% 6.7 7. ( )103 1-11 61 3,113 8. 179 27 11 9. 103 - 7,082 103 7 338 10. 98 103 204 2,835 40
41. 41. 11. 103 14 958 12 706 24 2,146 7 661 252 (6) 1. 103 70 114 1.6 2. 1 13 101 30.4% 103 33% 3. 4. 103 8 42 6 41
42. 42. 4 5. (7) 1. e 103 12 708 (8) 1. 103 9 103 103 20,060 2. 103 45 103 12 2 1,739 3. 103 1-6 14,292 5,365 7 6,334 4. 104 1 14 5. 103 204 87 42
43. 43. 40 103 12 9,200 103 2,268 (1) 1. 1 103 12 193 31 84 78 2 102 104 4 19 17 67 ( 52 15 ) 43
44. 44. 3 AED 102 14 114 2 7 22 AED AED tw-aed.mohw.gov.tw 103 4,600 AED CPR+AED 1200 2. 44
45. 45. 3 103 20 20 900 18,000 (2) 1. 11 2. 102 5 16 / 102 103 104 3. 45
46. 46. 4. 103 30-50%104 5. 24 106 103 1 29 6. () 1 24 46
47. 47. 2 3 () 4 102 ( ) 47
48. 48. 5 Youtube 7. 103 10 29 8. 1 101 10 1 3 103 12 250 10 20 236 196 1 8,996 2 100 30 8.5 72% 3 103 5 8 103 5 29 48
49. 49. 9. 567 10. 101 5 10 6 10 15 1 1) : 102103 104 2) : 103 20 4 3) : 102 49
50. 50. 2 1) : 103 20 98 102 6,205 102 (34.0%) (22.7%)(18.1%) (14.9%)(10.2%) 2) :101 9 1 ()103 ()80% 160 ~166 8.08%(100 40,355 101 42,134 102 43,296 ) 3 1) 50
51. 51. 84 1( ) 2) : 103 1 20 4 104 3) : 103 1 29 24 106 51
52. 52. 4 : 103 6 19 104 4 200 30 4 5 (101 4 ) 136,415 103 12 147,818 11,403 101 13.14% 102 11.2% 99 100 7.4%101 7.2% 102 6.3% 11. 103 8 5 24 52
53. 53. 95 103 5,026 ( 2,670 2,356 ) (3) 1. 14 103 133 25,792 2. 103 40 1,395 3. 102 (OSCE) 102 22 103 1,430 (4) 1. 103 51 2. 103 3 20 53
54. 54. 4 103 10 1 4 3. 103 2 26 18 : () 28 4 4. 51 77 112 104 2 27 3,548 (5) 1. 1 13 54
55. 55. 2 3 24 0800-788-995103 7 3,309 12,854 525 103 2 9,059 19 6,834 4 102 12 4 10 103 1-11 2,836 102 464 14.1% 2. 1 55
56. 56. schizophrenia () 3 2 96 103 14 1,801 71 4,617 5.04 58% 3 103 114 25 4 103 1-12 766 94.7% 682 94.99% 44 91.67% 3. 1 103 158 150 96 56
57. 57. 1 4,131 103 4 1,017 100 7 7 94 2,420 102 39 103 7 ( ) 2 4. 102 1,026 363 1,078 1,593 438 501 () 406 5. 57
58. 58. 1 103 51 2 5 3 103 18,457 4 6 6. 103 277 680 58
59. 59. 7. 1 103 29 3 111 5 2 103 3 22 89 (6) 1. 103 28 136 2. 2 59
60. 60. (7) - 1. 1 102 1 6 103 6 27 101 2 101 102 12 4 103 159 84 48 24 3 3 100 1 21 64 60
61. 61. 2013 4 (HIS) (PACS) 103 1,536 100-104 3,247 2. 1 2 24 3 4 102 5 61
62. 62. 6 3. 102 104 19 17 4. 102 48 104 1 HIS PACS 103 7,496 2 102 48 103 5. IDS IDS 48 319 IDS 6. 62
63. 63. 9 17 24 7. 1 869 7 104-105 98 2 (246 ) 3 : 104 4 200 30 4 4 : 30 216 () 27 5 : 63
64. 64. 8. 24 103 286 236 82.52% 240 1.67% () (8) 1. 1 101 103 128 143 24 2 103 24 64
65. 65. 103 14,939 2,013 15,285 3 19 103 12 3,276 3,464 3,272 4 2,027 (1,724 300 3 ) 2. 103 21 ( 17 ) 343 750 340 45% () 3. 1 4 (IRC) 65
66. 66. 2 99 2 103 12 16 20 17 7,257 3 0,168 20 7,425 4. 87 3 2 ( ) 5. 18 6. () ( 66
67. 67. )() () 90 103 1,065 17 1,158 185 7. 1 15 2 (1) 1. 103 4,063 ( ) 67
68. 68. 2. 102 12 103 12 3. 103 18 (2) 1. 103 71 4,685 4 8,580 630 2. 103 12 10 68
69. 69. 3. 1 102 12 3 1) 103 4 24 103 5 1 103 10 1 2) 103 10 16 103 12 31 103 10 31 2 102 11 19 69
70. 70. 103 10 27 9 103 10 31 8 104 2 5 103 12 31 (3) MIT 1. GMP (PIC/S GMP) 103 12 31 103 12 24 142 34 5 21 ( 163 )4 GMP 92 34 PIC/S GMP 103 12 70
71. 71. 24 865 PIC/S GMP (GMP)103 12 1 GMP/QSD 3,622 15.5% 84.5 % 2. 103 1 103 7 1 CTD 2103 12 12 3 103 7 8 ()8 28 9 18 71
72. 72. 10 1 104 7 1 GCP 10 2 11 19 () 4/ (ICH) 103 10 17 / 5 103 11 7 6103 11 6 Cholic acid 7 72
73. 73. 8 9 9 (GSP) 3. 1 103 12 44 12 10 3 11 3 3 24 34 41.6 % 4. 103 11 198 87 4 2,401 161 73
74. 74. 99 (IMDRF)(NCAR) 103 12 19 NCAR 331 2,958 72 5. // 104 1 1 6. 103 12 1074 359 347 9 3 206 171 3 25 7 509 472 37 7. 103 7 8. 103 1 22 74
75. 75. 9 25 9. 103 12 6,077 15,643.1 99 1 13.9% 103 12 4.97% 10. 103 48 11. 103 22 112 (4) 1. 103 11 1 6,733 279 (1.67%) 2. 103 10 1 4,906 1 6,522 9.8% 75
76. 76. (5) 1. 103 12 336 4,565.8 41 127.5 48 194.6 2. 103 12 10 5,657 2 3. 103 12 49 GMP 2 95.92 4. 103 7 1 22 5. 103 7 1 (1) 1. 103-104 ( 103 8 1 ) 104 3 5 172 76
77. 77. 31 2. 10-15% 3. 103 103 10 1 104 2 27 289 ( 97%) 65 100 103.8 114.3 40.7 4. 5. 1 103 7 1 H5N1 H7N9 A A A 103 7 1 104 3 5 43 2 103 5 2 77
78. 78. 102 5 17 103 12 31 64,106 151 122 (80%) (2) 1. 103 104 3 5 15,567 15,077 218 153 16 119 2. 3 3. 103 2,000 6 3,000 4. (3) 1. 104 3 5 1 B5103 A 78
79. 79. 101 102 2. 103 71 (4) 1. 94-102 102 49.4 (WEF) TB 12 72 2. 103 WHO 2035 (105 -109 ) 3. (DOTS)103 12,519 97% 103 193 79
80. 80. 4. X 103 5,575 5. 15-49 17% 73% 6. (5) 1. 103 12 2 8,711 103 2,236 103 0.36% 2009 2,039 1,801 238 91.19%15-24 658 29.43 80
81. 81. 2. 5 9 () 3. 103 9 791 411 90% 4. ( ) 103 12 13 8,327 5. 103 56 103 11 1 7,318 6. 81
82. 82. 7. (6) 1. (IPD) (PCV) 5 / (PCV) 102 3 2 5 103 (PCV) 1 5 104 1 2. 103 1 100 (7) 1. 103 4 1 (WHO) 103 8 8 (PHEIC) 82